Literature DB >> 24296139

Exhaled breath condensate: determination of non-volatile compounds and their potential for clinical diagnosis and monitoring. A review.

Petr Kubáň1, František Foret.   

Abstract

Exhaled breath condensate is a promising, non-invasive, diagnostic sample obtained by condensation of exhaled breath. Starting from a historical perspective of early attempts of breath testing towards the contemporary state-of-the-art breath analysis, this review article focuses mainly on the progress in determination of non-volatile compounds in exhaled breath condensate. The mechanisms by which the aerosols/droplets of non-volatile compounds are formed in the airways are discussed with methodological consequences for sampling. Dilution of respiratory droplets is a major problem for correct clinical interpretation of the measured data and there is an urgent need for standardization of EBC. This applies also for collection instrumentation and therefore various commercial and in-house built devices are described and compared with regard to their design, function and collection parameters. The analytical techniques and methods for determination of non-volatile compounds as potential markers of oxidative stress and lung inflammation are scrutinized with an emphasis on method suitability, sensitivity and appropriateness. The relevance of clinical findings for each group of possible non-volatile markers of selected pulmonary diseases and methodological recommendations with emphasis on interdisciplinary collaboration that is essential for future development into a fully validated clinical diagnostic tool are given.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  3-NT; 3-nitrotyrosine; 5-HPETE; 5-LO; 5-hydroperoxyeicosatetraenoic acid; 5-lipoxygenase; 8-IP; 8-isoprostane; ALF; Analytical techniques; BAL; CF; COPD; COX; EBC; Exhaled breath condensate (EBC); FDA; GSH; GSSG; INF-γ; Ions; LT; Metabolites; NMR; PCA; PE; PG; PLS; PLS-DA; PP; PTFE; Proteins; ROS; RS–NO; S-nitrosothiols; SI; TNF-α; U.S. Food and Drug Administration; VOC; airway lining fluid; bronchoalveolar lavage; chronic obstructive pulmonary disease; cyclooxygenase; cystic fibrosis; exhaled breath condensate; glutathione; glutathione disulfide; interferon γ; leukotriene; nuclear magentic resonance; partial least squares; partial least squares discriminant analysis; polyethylene; polypropylene; polytetrafluoroethylene; principal component analysis; prostaglandin; reactive oxygen species; sputum induction; tumor necrosis factor α; volatile organic compounds

Mesh:

Substances:

Year:  2013        PMID: 24296139     DOI: 10.1016/j.aca.2013.07.049

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  32 in total

1.  A new hypothesis to investigate bioequivalence of pharmaceutical inhalation products.

Authors:  Maryam Khoubnasabjafari; Elaheh Rahimpour; Morteza Samini; Vahid Jouyban-Gharamaleki; Lan Chen; Donghao Chen; Hak-Kim Chan; Abolghasem Jouyban
Journal:  Daru       Date:  2019-03-07       Impact factor: 3.117

2.  Quantitative mass spectrometry of unconventional human biological matrices.

Authors:  Ewelina P Dutkiewicz; Pawel L Urban
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2016-10-28       Impact factor: 4.226

3.  Human breath metabolomics using an optimized non-invasive exhaled breath condensate sampler.

Authors:  Konstantin O Zamuruyev; Alexander A Aksenov; Alberto Pasamontes; Joshua F Brown; Dayna R Pettit; Soraya Foutouhi; Bart C Weimer; Michael Schivo; Nicholas J Kenyon; Jean-Pierre Delplanque; Cristina E Davis
Journal:  J Breath Res       Date:  2016-12-22       Impact factor: 3.262

4.  Analytical methodologies for broad metabolite coverage of exhaled breath condensate.

Authors:  Alexander A Aksenov; Konstantin O Zamuruyev; Alberto Pasamontes; Joshua F Brown; Michael Schivo; Soraya Foutouhi; Bart C Weimer; Nicholas J Kenyon; Cristina E Davis
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2017-06-27       Impact factor: 3.205

Review 5.  Exhaled Breath Condensate (EBC): Is It a Viable Source of Biomarkers for Lung Diseases?

Authors:  Stefanos Patsiris; Themis Exarchos; Panayiotis Vlamos
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 6.  A review of metabolomics approaches and their application in identifying causal pathways of childhood asthma.

Authors:  Kedir N Turi; Lindsey Romick-Rosendale; Kelli K Ryckman; Tina V Hartert
Journal:  J Allergy Clin Immunol       Date:  2017-05-04       Impact factor: 10.793

7.  Influence of air pollution on airway inflammation and disease activity in childhood-systemic lupus erythematosus.

Authors:  Andressa Guariento Ferreira Alves; Maria Fernanda de Azevedo Giacomin; Alfésio Luis Ferreira Braga; Adriana Maluf Elias Sallum; Luiz Alberto Amador Pereira; Luis Carlos Farhat; Fernando Louzada Strufaldi; Ana Julia de Faria Coimbra Lichtenfels; Tômas de Santana Carvalho; Naomi Kondo Nakagawa; Clovis Artur Silva; Sylvia Costa Lima Farhat
Journal:  Clin Rheumatol       Date:  2017-11-02       Impact factor: 2.980

8.  Enhanced non-invasive respiratory sampling from bottlenose dolphins for breath metabolomics measurements.

Authors:  Konstantin O Zamuruyev; Alexander A Aksenov; Mark Baird; Alberto Pasamontes; Celeste Parry; Soraya Foutouhi; Stephanie Venn-Watson; Bart C Weimer; Jean-Pierre Delplanque; Cristina E Davis
Journal:  J Breath Res       Date:  2016-09-30       Impact factor: 3.262

9.  Standardization of the collection of exhaled breath condensate and exhaled breath aerosol using a feedback regulated sampling device.

Authors:  Brett R Winters; Joachim D Pleil; Michelle M Angrish; Matthew A Stiegel; Terence H Risby; Michael C Madden
Journal:  J Breath Res       Date:  2017-11-01       Impact factor: 3.262

Review 10.  Evolution of clinical and environmental health applications of exhaled breath research: Review of methods and instrumentation for gas-phase, condensate, and aerosols.

Authors:  M Ariel Geer Wallace; Joachim D Pleil
Journal:  Anal Chim Acta       Date:  2018-02-09       Impact factor: 6.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.